STEPHANIE VIA: Open Payments
NPI 1891363883 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 60 payments from 17 companies in 2025. Trend: 2023 $1,284 · 2024 $1,357 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $216 |
| AstraZeneca Pharmaceuticals LP | 4 | $209 |
| Novartis Pharmaceuticals Corporation | 6 | $140 |
| Lilly USA, LLC | 10 | $136 |
| Novo Nordisk Inc | 5 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| Biogen, Inc. | 3 | $65 |
| PFIZER INC. | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
Products named: FARXIGA, LEQVIO, MOUNJARO, QULIPTA, VRAYLAR, CAPLYTA, ZURZUVAE, UBRELVY.
Industry payments across KY — which companies pay providers there.
